Monsanto Company (MON) Shares Sold by Chesley Taft & Associates LLC

Chesley Taft & Associates LLC decreased its stake in Monsanto Company (NYSE:MON) by 1.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 59,746 shares of the basic materials company’s stock after selling 575 shares during the period. Chesley Taft & Associates LLC’s holdings in Monsanto were worth $7,072,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the company. Delta Asset Management LLC TN raised its stake in shares of Monsanto by 0.5% in the first quarter. Delta Asset Management LLC TN now owns 1,950 shares of the basic materials company’s stock valued at $221,000 after buying an additional 10 shares during the period. Savant Capital LLC raised its stake in shares of Monsanto by 0.4% in the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock valued at $349,000 after buying an additional 11 shares during the period. Guardian Life Insurance Co. of America raised its stake in shares of Monsanto by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock valued at $191,000 after buying an additional 11 shares during the period. Greenwich Wealth Management LLC raised its stake in shares of Monsanto by 0.6% in the first quarter. Greenwich Wealth Management LLC now owns 2,565 shares of the basic materials company’s stock valued at $290,000 after buying an additional 15 shares during the period. Finally, Dubuque Bank & Trust Co. raised its stake in shares of Monsanto by 0.7% in the first quarter. Dubuque Bank & Trust Co. now owns 3,425 shares of the basic materials company’s stock valued at $388,000 after buying an additional 25 shares during the period. 75.31% of the stock is owned by hedge funds and other institutional investors.

Monsanto Company (NYSE MON) traded down 0.18% on Friday, hitting $116.73. The company’s stock had a trading volume of 534,459 shares. The firm has a 50 day moving average of $117.48 and a 200 day moving average of $115.03. The firm has a market cap of $51.28 billion, a price-to-earnings ratio of 25.21 and a beta of 1.07. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $118.97.

Monsanto (NYSE:MON) last announced its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The company had revenue of $4.23 billion during the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. Monsanto’s revenue was up 1.0% compared to the same quarter last year. During the same period last year, the firm earned $2.17 earnings per share. Equities research analysts forecast that Monsanto Company will post $4.89 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 1.85%. Monsanto’s dividend payout ratio (DPR) is 46.75%.

WARNING: This story was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.com-unik.info/2017/08/11/monsanto-company-mon-shares-sold-by-chesley-taft-associates-llc.html.

Several brokerages have issued reports on MON. UBS AG lowered Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. BidaskClub lowered Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Wednesday, June 21st. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target for the company in a research note on Tuesday, June 27th. Finally, Susquehanna Bancshares Inc reaffirmed a “neutral” rating and set a $128.00 price target (up previously from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $123.15.

In other Monsanto news, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the sale, the executive vice president now directly owns 55,011 shares in the company, valued at $6,522,654.27. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Janet M. Holloway sold 3,337 shares of the firm’s stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $118.00, for a total transaction of $393,766.00. Following the completion of the sale, the senior vice president now owns 44,405 shares of the company’s stock, valued at $5,239,790. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 74,470 shares of company stock valued at $8,791,281. 0.79% of the stock is owned by insiders.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

What are top analysts saying about Monsanto Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Monsanto Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit